Tumour radiotherapy may prolong survival of non-small cell lung cancer patients undergoing novel chemotherapy formulation

Patients with un-resectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiotherapy.
News Medical Life Sciences